July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Rami Manochakian: FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer Based on TRUST Trials
Jun 12, 2025, 19:07

Rami Manochakian: FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer Based on TRUST Trials

Rami Manochakian, Vice President of the North American Neuroendocrine Tumor Society, shared on X:

“Hot Off The Press
U.S. FDA approves Taletrectinib for locally advanced or metastatic ROS1+ non-small cell Lung Cancer.
Approval based on TRUST I and II Trials.
– ORR:
85-90% for treatment-naive patients
52-62% or TKI-pretreated patients”

Read the full article.

Taletrectinib

More posts featuring Rami Manochakian on OncoDaily.